SCHEMBL6628686

SCHEMBL6628686

COc1ccc(Oc2ccccc2C(N)=O)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.56
NNMT P40261 3/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
CYP3A4 P08684 2/20 0.49
MAPT P10636 2/20 0.49
NR1I2 O75469 1/20 0.49
LMNA P02545 1/20 0.49
CHRM2 P08172 1/20 0.49
ADRA2A P08913 1/20 0.49
OPRK1 P41145 1/20 0.49
HTR2B P41595 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
MKNK1 Q9BUB5 1/20 0.47
MKNK2 Q9HBH9 1/20 0.47
MAPK8 P45983 4/20 0.46
MAPK10 P53779 4/20 0.46
HTT P42858 2/20 0.46
IRAK4 Q9NWZ3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628177 0.83 CTNNB1 (0.59) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL6630091 0.80 CTNNB1 (0.59) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL6634137 0.77 CTNNB1 (0.55) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL5971904 0.76 CTNNB1 (0.54) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL5175230 0.75 HTT (0.73) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL6629908 0.74 CTNNB1 (0.51) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL6368241 0.74 CTNNB1 (0.74) CTNNB1MEN1KMT2ACYP3A4MAPT
Methyl Alcohol SCHEMBL8782982 0.74 CTNNB1 (0.93) CTNNB1MEN1KMT2ACYP3A4MAPT
SCHEMBL1702138 0.74 CTNNB1 (0.68) CTNNB1LMNAMKNK1MKNK2HTT
SCHEMBL30060692 0.74 CTNNB1 (0.68) CTNNB1LMNAMKNK1MKNK2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480977-A2 SUBSTITUTED ARYL COMPOUNDS FOR TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-12-01 EP disclosed
EP-1387830-A1 NOVEL 4-ANILINOQUINOLINE-3-CARBOXAMIDES AstraZeneca AB (SE) 2004-02-11 EP disclosed
WO-2003070728-A2 AZABICYCLO-SUBSTITUTED BENZOYLAMIDES AND THIOAMIDES FOR TREATMENT OF CNS-RELATED DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2003-08-28 WO disclosed
WO-2002092571-A1 NOVEL 4-ANILINOQUINOLINE-3-CARBOXAMIDES ASTRAZENECA AB (SE) 2002-11-21 WO disclosed